TrialEBioMedicine2025

Safety and efficacy of intratumourally administered INT230-6 in adult patients with advanced solid tumours: results from an open-label phase 1/2 dose escalation study.

Jacob S Thomas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.